Publication | Open Access

Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts

Tetrahydrofurofuran-type LignansBreast OncologyOncologyMedicineVicious CycleBreast CancerAnti-cancer AgentCancer CellsPharmacologyCell BiologyOsteoporosisCancer ResearchEndocrine-related Cancer